Akttyva Therapeutics
Developing therapeutics using state-of-the-art AI-assisted in silico screening protocols and compound libraries
Boston, United States
4 employees
Grant
Total: $255.49K
Health Care, Health and Wellness
General Information
Get notified when Akttyva Therapeutics moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Akttyva Therapeutics
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Health Care
About Akttyva Therapeutics
Taxonomy: Therapeutics, AI-assisted, In silico screening, NSF-funded, Discovery, Development, Proprietary computational tools, Compound libraries, Targeted therapeutics, Cell barrier dysfunction, Medical needs
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | •••••• | 1 |
|
30 Nov 2021 |
| Non Equity Assistance | •••••• | 1 |
|
28 Jun 2021 |
Akttyva Therapeutics Alternatives & Competitors
Providing high quality research services. We have the know-how you need.
Pioneering treatments to empower physicians in addressing metabolic disorders with advanced protein...
FAQ About Akttyva Therapeutics
Don't just browse. Track.
Signal Tracker monitors Akttyva Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
